DigiNepal

A Key Biomarker lnc-ABCA12-5:2 Compensating Diagnostic Deficiencies for Indeterminate Thyroid Nodules and Genetically Wild-Type Thyroid Malignancies

Oncology Research · Xuan Su, Wen-na Xu, Bu Zou et al. · 2026

  • EnglishRead in your language
  • CitedEvery fact sourced
  • Ad-freeNo ads, no tracking

Quick facts

Author
Xuan Su, Wen-na Xu, Bu Zou, Chan Huang, Cai-yun He, Zu-lu Ye ref
Published
ref
Publisher
Tech Science Press ref
Journal
Oncology Research ref

Questions

Who wrote A Key Biomarker lnc-ABCA12-5:2 Compensating Diagnostic Deficiencies for Indeterminate Thyroid Nodules and Genetically Wild-Type Thyroid Malignancies?
A Key Biomarker lnc-ABCA12-5:2 Compensating Diagnostic Deficiencies for Indeterminate Thyroid Nodules and Genetically Wild-Type Thyroid Malignancies was written by Xuan Su, Wen-na Xu, Bu Zou, Chan Huang.
When was A Key Biomarker lnc-ABCA12-5:2 Compensating Diagnostic Deficiencies for Indeterminate Thyroid Nodules and Genetically Wild-Type Thyroid Malignancies first published?
A Key Biomarker lnc-ABCA12-5:2 Compensating Diagnostic Deficiencies for Indeterminate Thyroid Nodules and Genetically Wild-Type Thyroid Malignancies was first published in 2026.

Sources

  1. Publisher record (DOI, via Crossref)

Last updated · facts checked 20 October 2026

Cite this page

"A Key Biomarker lnc-ABCA12-5:2 Compensating Diagnostic Deficiencies for Indeterminate Thyroid Nodules and Genetically Wild-Type Thyroid Malignancies". DigiNepal. Last updated 20 October 2026. https://diginpl.com/books/paper-or-2026-088872. Retrieved 14 November 2026.

Machine-readable versions: JSON · Markdown

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.088872.

← Books